High-Efficacy Therapy Discontinuation vs Continuation in Patients 50 Years and Older With Nonactive MS. - Jouvenot G; Courbon G; Lefort M; Rollot F; Casey R; Le Page E; Michel L; Edan G; de Seze J; Kremer L; Bigaut K; Vukusic S; et al. (JAMA neurology, 2024)